S. Hardman, S. Muthukrishnan, Benjamin Jacobs, Augusta Trussell, A. Chesterton
The COVID‐19 pandemic presents unprecedented challenges to health care services across the world. When the pandemic first emerged in early 2020, health care services were forced to adapt to the new climate created by the pandemic. Here, the authors describe a case series of patients admitted to an older adult psychiatric unit when the pandemic struck, with themed discussions pertinent to the cases and an exploration of how staff adapted to this new and unfamiliar environment.
{"title":"Patients in older adult psychiatric hospital during first COVID‐19 wave","authors":"S. Hardman, S. Muthukrishnan, Benjamin Jacobs, Augusta Trussell, A. Chesterton","doi":"10.1002/pnp.736","DOIUrl":"https://doi.org/10.1002/pnp.736","url":null,"abstract":"The COVID‐19 pandemic presents unprecedented challenges to health care services across the world. When the pandemic first emerged in early 2020, health care services were forced to adapt to the new climate created by the pandemic. Here, the authors describe a case series of patients admitted to an older adult psychiatric unit when the pandemic struck, with themed discussions pertinent to the cases and an exploration of how staff adapted to this new and unfamiliar environment.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42844241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Risperidone is a commonly used antipsychotic. Due to its widespread use, health professionals are well aware of its common side‐effects. However, there are some side‐effects (though rare in practice) that are disabling, distressing and cause severe suffering to patients, and these can have the potential of being missed. Here the authors report one such side‐effect of risperidone, namely polyarthralgia.
{"title":"Polyarthralgia with oral risperidone","authors":"T. Mashimo, S. Paul","doi":"10.1002/pnp.734","DOIUrl":"https://doi.org/10.1002/pnp.734","url":null,"abstract":"Risperidone is a commonly used antipsychotic. Due to its widespread use, health professionals are well aware of its common side‐effects. However, there are some side‐effects (though rare in practice) that are disabling, distressing and cause severe suffering to patients, and these can have the potential of being missed. Here the authors report one such side‐effect of risperidone, namely polyarthralgia.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49583827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Yahya, Shakil Khawaja, Paul Simon Williams, Meena Naguib
Borderline personality disorder (BPD) is a complex and serious mental disorder that has a high suicide rate. There is emerging evidence for the use of nonconvulsive neurostimulation therapies, including transcranial magnetic stimulation (TMS), repetitive TMS (rTMS), and transcranial direct current stimulation (tDCS) in controlling some of the characteristic symptoms. Here the authors summarise the current evidence for the efficacy and tolerability of TMS, rTMS and tDCS in managing symptoms of BPD.
{"title":"Neuromodulation approaches for borderline personality disorder","authors":"A. Yahya, Shakil Khawaja, Paul Simon Williams, Meena Naguib","doi":"10.1002/pnp.740","DOIUrl":"https://doi.org/10.1002/pnp.740","url":null,"abstract":"Borderline personality disorder (BPD) is a complex and serious mental disorder that has a high suicide rate. There is emerging evidence for the use of nonconvulsive neurostimulation therapies, including transcranial magnetic stimulation (TMS), repetitive TMS (rTMS), and transcranial direct current stimulation (tDCS) in controlling some of the characteristic symptoms. Here the authors summarise the current evidence for the efficacy and tolerability of TMS, rTMS and tDCS in managing symptoms of BPD.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49067822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Man has lived with parasites for millennia and evidence is emerging of their impact on mental health. Here the author considers parasites’ contribution to the global burden of neurological and psychiatric disease.
{"title":"Parasites and mental health","authors":"M. Greener","doi":"10.1002/pnp.733","DOIUrl":"https://doi.org/10.1002/pnp.733","url":null,"abstract":"Man has lived with parasites for millennia and evidence is emerging of their impact on mental health. Here the author considers parasites’ contribution to the global burden of neurological and psychiatric disease.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42824771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
wchh.onlinelibrary.wiley.com 4 I Progress in Neurology and Psychiatry I Vol. 26 Iss. 1 2022 Autism (referred to as ‘autism spectrum disorder’ in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders) is a lifelong neurodevelopmental condition, characterised by difficulties in social communication and social interaction, and restricted, repetitive behaviours, interests or activities.1 Prevalence refers to the proportion of individuals in a population who have a specific condition or characteristic at a specific time (point prevalence) or time period (period prevalence).2 Reliably estimating autism prevalence is essential to estimate need and allocation of health and social care resources. Similarly, identifying autism on an individual level is important, as late-diagnosed autistic persons describe receiving their diagnosis as life-changing, enabling access to valuable forms of support.3 This article discusses different approaches to case ascertainment employed in autism prevalence studies, and their merits and disadvantages. Though this paper pertains to autism epidemiology, it is important to acknowledge that many of the underlying principles were developed outside of autism research.
{"title":"Autism epidemiology: distinguishing between identification and prevalence","authors":"S. Tromans, T. Brugha","doi":"10.1002/pnp.732","DOIUrl":"https://doi.org/10.1002/pnp.732","url":null,"abstract":"wchh.onlinelibrary.wiley.com 4 I Progress in Neurology and Psychiatry I Vol. 26 Iss. 1 2022 Autism (referred to as ‘autism spectrum disorder’ in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders) is a lifelong neurodevelopmental condition, characterised by difficulties in social communication and social interaction, and restricted, repetitive behaviours, interests or activities.1 Prevalence refers to the proportion of individuals in a population who have a specific condition or characteristic at a specific time (point prevalence) or time period (period prevalence).2 Reliably estimating autism prevalence is essential to estimate need and allocation of health and social care resources. Similarly, identifying autism on an individual level is important, as late-diagnosed autistic persons describe receiving their diagnosis as life-changing, enabling access to valuable forms of support.3 This article discusses different approaches to case ascertainment employed in autism prevalence studies, and their merits and disadvantages. Though this paper pertains to autism epidemiology, it is important to acknowledge that many of the underlying principles were developed outside of autism research.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42037061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A striking BBC headline reported: ‘How Norway is offering drug‐free treatment to people with psychosis’. On first impression this suggests a revolutionary treatment option in psychosis, or even an alternative to antipsychotic medication. In this review, Professor Chakraborty explores the past, present and future of the treatment of psychosis/schizophrenia in the context of these headlines and discusses the relevance to current treatment guidelines of psychosis in the UK.
{"title":"Medication‐free treatment for psychosis – an alternative to antipsychotics?","authors":"N. Chakraborty","doi":"10.1002/pnp.730","DOIUrl":"https://doi.org/10.1002/pnp.730","url":null,"abstract":"A striking BBC headline reported: ‘How Norway is offering drug‐free treatment to people with psychosis’. On first impression this suggests a revolutionary treatment option in psychosis, or even an alternative to antipsychotic medication. In this review, Professor Chakraborty explores the past, present and future of the treatment of psychosis/schizophrenia in the context of these headlines and discusses the relevance to current treatment guidelines of psychosis in the UK.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48948728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Individuals with schizophrenia can experience family and social adjustment difficulties as well as significant barriers to independent living, with cognitive difficulties being one of the pivotal features of this mental health disorder. This article examines a decade of data for a sample of individuals living with schizophrenia and argues that comprehensive assessment of personality and cognitive function in the initial stage of disease should inform management and treatment to enable improved patient life outcomes.
{"title":"Premorbid personality and cognitive function impact on schizophrenia","authors":"D. Samburskis, L. Renemane","doi":"10.1002/pnp.727","DOIUrl":"https://doi.org/10.1002/pnp.727","url":null,"abstract":"Individuals with schizophrenia can experience family and social adjustment difficulties as well as significant barriers to independent living, with cognitive difficulties being one of the pivotal features of this mental health disorder. This article examines a decade of data for a sample of individuals living with schizophrenia and argues that comprehensive assessment of personality and cognitive function in the initial stage of disease should inform management and treatment to enable improved patient life outcomes.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49455635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There is relatively limited understanding of issues relating to the transgender population in a dementia clinical service setting. Here, the authors present a case to discuss the challenges faced by the LGBT population in the context of dementia, exploring aspects such as the impact on carers and of dementia progression on gender‐related behaviour.
{"title":"Dementia in transgender population: case vignette","authors":"Nirja Beehuspoteea, V. Badrakalimuthu","doi":"10.1002/pnp.724","DOIUrl":"https://doi.org/10.1002/pnp.724","url":null,"abstract":"There is relatively limited understanding of issues relating to the transgender population in a dementia clinical service setting. Here, the authors present a case to discuss the challenges faced by the LGBT population in the context of dementia, exploring aspects such as the impact on carers and of dementia progression on gender‐related behaviour.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45702334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chromosome 15q11.2 microdeletion is an emerging syndrome identified in individuals with Prader‐Willi syndrome and Angelman syndrome but also found in isolation. Here, the authors present a case of a 19‐year‐old woman with chromosome 15q11.2 microdeletion and her successful treatment with risperidone, a tailored positive behaviour support plan and with staff training around non‐epileptic attack disorder.
{"title":"Risperidone in non‐epileptic attack disorder and chromosome 15q deletion syndrome","authors":"A. Javaid, David Kent, Joanne Bone, D. Michael","doi":"10.1002/pnp.725","DOIUrl":"https://doi.org/10.1002/pnp.725","url":null,"abstract":"Chromosome 15q11.2 microdeletion is an emerging syndrome identified in individuals with Prader‐Willi syndrome and Angelman syndrome but also found in isolation. Here, the authors present a case of a 19‐year‐old woman with chromosome 15q11.2 microdeletion and her successful treatment with risperidone, a tailored positive behaviour support plan and with staff training around non‐epileptic attack disorder.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47865478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Women are increasingly well represented in psychiatry as a profession, but data show us that it is not a level playing field. Written by the Chairs of the Women and Mental Health Special Interest Group (WMHSIG) of the Royal College of Psychiatrists, this article explores the work of the group in raising the profile of women's mental health issues and advancing future opportunities for leadership visibility in the profession of psychiatry.
{"title":"Women in psychiatry and women's mental health","authors":"Beena Rajkumar, R. Reed","doi":"10.1002/pnp.722","DOIUrl":"https://doi.org/10.1002/pnp.722","url":null,"abstract":"Women are increasingly well represented in psychiatry as a profession, but data show us that it is not a level playing field. Written by the Chairs of the Women and Mental Health Special Interest Group (WMHSIG) of the Royal College of Psychiatrists, this article explores the work of the group in raising the profile of women's mental health issues and advancing future opportunities for leadership visibility in the profession of psychiatry.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48240285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：